PathologybioRxivPreprint
MC1R reduces scarring and rescues stalled healing in a preclinical chronic wound model
Y. Nawilaijaroen, H. R. Rocliffe, S. Austin-Williams…·J. L. Cash
This study shows that MC1R agonist reduces scarring and improves healing in a chronic wound model by enhancing angiogenesis, lymphangiogenesis, and reducing inflammation.
DOI 10.1101/2022.11.30.518516